<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00953160</url>
  </required_header>
  <id_info>
    <org_study_id>C-09-TF-02</org_study_id>
    <nct_id>NCT00953160</nct_id>
  </id_info>
  <brief_title>Radio Frequency (RF) Device for Reduction in Size of Localized Areas of the Body</brief_title>
  <official_title>Pilot Study to Evaluate the Cutera RF Device for Reduction in Size of Localized Areas of the Body, Including, But Not Limited to, Areas on the Abdomen, Leg, and Arm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cutera Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cutera Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the Cutera radio frequency (RF) device for the new
      indication of reduction in size of localized areas of the body.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the Cutera radio frequency device for the new
      indication of reduction in size of localized areas of the body, including, but not limited
      to, areas on the abdomen, leg, and arm.

      At investigator's discretion, each subject will receive up to three treatments and will be
      scheduled for two follow-up visits after the final treatment. The treated area will be
      measured and photographed ar each visit for analysis. Subjects will also be weighted at each
      visit and asked to fill out a survey during follow-up visits.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The preliminary data from this pilot study did not indicate efficacy.
  </why_stopped>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Circumference (cm)</measure>
    <time_frame>Baseline and 6 months post final treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject Satisfaction</measure>
    <time_frame>Baseline and 6 months post final treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Number of Participants With Adverse Events</measure>
    <time_frame>Up to 6 months after the last treatment</time_frame>
    <description>At each visit (treatment and follow-up) or until resolution of AEs</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Cellulite</condition>
  <arm_group>
    <arm_group_label>RF treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Abdomen, flank or thigh treated with RF device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cutera Radio Frequency Device</intervention_name>
    <description>Up to three treatments, one pass, dosage range of 15-60 kJ.</description>
    <arm_group_label>RF treatment</arm_group_label>
    <other_name>Callisto, TruForm, TruSculpt</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female or Male

          -  Minimum age of 18 years

          -  Non-smoking for at least 3 months and willing to refrain from smoking for the duration
             of the study.

          -  Post-menopausal, or on birth control with no plans to become pregnant for the duration
             of the study (female only)

          -  Minimum Body Mass Index of 20

          -  Visible fat in the area to be treated Area to be treated to measure at least 20.0mm in
             vertical fold, as measured with industry standard fat caliper

          -  Subject must be able to read, understand and sign the Consent Form

          -  Subject must adhere to the follow-up schedule and study instructions

          -  Subject must adhere to the same diet and/or exercise routine throughout the study, and
             agree to maintain the same weight throughout the study (within 6 lbs of initial
             weight)

        Exclusion Criteria:

          -  Significant weight fluctuation (+/-10 lbs) in the past 6 months

          -  Taking weight-loss medications/supplements

          -  Participation in any other clinical study

          -  Cellulite treatment within 3 months of the treatment

          -  Surgical or non-surgical treatments to the target area in the last 12 months, e.g.,
             liposuction

          -  Prior treatment to the target area within the last 12 months

          -  Arteriosclerosis or weakened blood vessels

          -  Heart disease

          -  Thromboembolic disease

          -  Diagnosed or documented immune system disorders

          -  Bleeding disorders.

          -  Presence of uncontrolled hypertension

          -  Taking prescription anticoagulants

          -  History of keloid formation

          -  Malignant tumors in the target area

          -  Diabetes

          -  Any disease or condition that could impair wound healing

          -  Skin abnormalities in the target area, e.g., cuts, scrapes, wounds, scars, large moles

          -  Infection in the target area

          -  Implanted electrical device(s)

          -  Pregnant or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Biesman, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Jacqueline Calkin, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Stephen Ronan, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Scott Kramer, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Adele Makow, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Barry DiBernardo, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Blackhawk Plastic Surgery</name>
      <address>
        <city>Danville</city>
        <state>California</state>
        <zip>94506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renu LaserSpa</name>
      <address>
        <city>Dublin</city>
        <state>California</state>
        <zip>94568</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Calkin/Boudreaux Dermatology Associates</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95825-6372</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Jersey Plastic Surgery</name>
      <address>
        <city>Montclair</city>
        <state>New Jersey</state>
        <zip>07042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nashville Center for Laser and Facial Surgery</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2009</study_first_submitted>
  <study_first_submitted_qc>August 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2009</study_first_posted>
  <results_first_submitted>February 25, 2011</results_first_submitted>
  <results_first_submitted_qc>February 25, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 17, 2011</results_first_posted>
  <last_update_submitted>June 21, 2013</last_update_submitted>
  <last_update_submitted_qc>June 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cellulite</keyword>
  <keyword>Adipose tissue</keyword>
  <keyword>Circumference</keyword>
  <keyword>Reduction</keyword>
  <keyword>Thigh</keyword>
  <keyword>Abdomen</keyword>
  <keyword>Flank</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cellulite</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study subjects were recruited in the medical clinic 01/01/09 through 01/13/10.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Radiofrequency (RF) Treatment</title>
          <description>Abdomen, flank or thigh treated with RF device (average of 2 treatments and average dosage of 30kJ)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Radiofrequency (RF) Treatment</title>
          <description>Abdomen, flank or thigh treated with RF device (average of 2 treatments and average dosage of 30kJ)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="76"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Circumference (cm)</title>
        <time_frame>Baseline and 6 months post final treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Radiofrequency (RF) Treatment</title>
            <description>Abdomen, flank or thigh treated with RF device (average of 2 treatments and average dosage of 30kJ)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Circumference (cm)</title>
          <units>Centimeters (cm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Abdomen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thigh</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Flank</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.4" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Satisfaction</title>
        <time_frame>Baseline and 6 months post final treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Radiofrequency (RF) Treatment</title>
            <description>Abdomen, flank or thigh treated with RF device (average of 2 treatments and average dosage of 30kJ)</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Satisfaction</title>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Number of Participants With Adverse Events</title>
        <description>At each visit (treatment and follow-up) or until resolution of AEs</description>
        <time_frame>Up to 6 months after the last treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Radiofrequency (RF) Treatment</title>
            <description>Abdomen, flank or thigh treated with RF device (average of 2 treatments and average dosage of 30kJ)</description>
          </group>
        </group_list>
        <measure>
          <title>The Number of Participants With Adverse Events</title>
          <description>At each visit (treatment and follow-up) or until resolution of AEs</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Edema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lumps</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>Subjects were assessed and followed up for adverse events at 6 weeks, 3 months and 6 months after the RF treatment.</desc>
      <group_list>
        <group group_id="E1">
          <title>Radiofrequency (RF) Treatment</title>
          <description>Abdomen, flank or thigh treated with RF device (average of 2 treatments and average dosage of 30kJ)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Lumps</sub_title>
                <counts group_id="E1" events="49" subjects_affected="3" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>&quot;The Doctor will not publish or present the results of the Study, or speak publicly about it, unless Cutera has first had a reasonable opportunity to review and comment on the contents of the proposed presentation or publication.&quot;</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination of the study resulting in analysis of small numbers of subjects, and technical issues with repeatability and reproducibility of circumference measurements leading to termination.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Ayse Turley, Clinical Development Researcher</name_or_title>
      <organization>Cutera Inc.</organization>
      <phone>415-657-5665</phone>
      <email>aturley@cutera.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

